BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15231207)

  • 1. [The effect of postoperative chemotherapy after esophagectomy on the survival rate to patients with original squamous cell carcinoma of esophagus].
    Liu J; Wang YK; Liu Y; Zhang L; Chen JH; Zheng W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):346-50. PubMed ID: 15231207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
    Liu BD; Zhi XY; Xu QS
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):586-9. PubMed ID: 15949351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
    Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
    Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
    Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
    J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
    Yuequan J; Shifeng C; Bing Z
    Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus].
    Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
    Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
    J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
    Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
    World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.